Pharmaceutical Technology Editors

GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.

GSK Australia's Boronia site will install next-generation blow-fill-seal machinery for aseptic filling.

FDA opens public docket on proposed criteria for “first generic” ANDAs.

Revised EMA policy reflects more balanced approach and experts are to submit updated declarations of interests by end of January 2015.

Shire will establish its US operational headquarters in Massachusetts and relocate staff from Pennsylvania.

CDMO Vetter has opened a new representative office in Singapore in response to growing market demand in Asia.

USP and ChP jointly host two-day meeting to strengthen cooperation.

Grand River Aseptic Manufacturing has announced that the company executed two commercial production contracts in one day.

FDA issues draft guidance on rare pediatric disease priority review vouchers in accordance with FDASIA.

In response to the Ebola outbreak in West Africa, Nitritex has donated seven pallets of personal protection equipment (PPE), including disposable coveralls, aprons, and more than 200,000 gloves to protect the healthcare workers helping to save lives during this crisis.

The agency cites deviations from CGMPs for the manufacture of APIs at the company?s Gujarat, India plant.

The Alios Biopharma acquisition strengthens J&J's infectious disease pipeline.

USP releases compendium of quality standards for compounded medicines.

ValiRx entered into a collaboration agreement with the Deutsches Krebsforschungzentrum cancer research center.

Catalent has acquired Micron Technologies, a provider of particle size engineering technologies.

Threshold Pharmaceuticals' anticancer drug TH-302 receives FDA Fast Track designation.

Celerion has expanded its laboratory capabilities in response to increasing demand for cell-based assays.

GE Healthcare and Takeda Pharmaceutical Company announced an alliance to develop therapeutic drugs in the field of hepatic fibrosis to treat various liver diseases.

AVEO enters into a research and exclusive option agreement with Ophthotech for tivozanib (AV-951) for the treatment of ocular diseases

The European Medicines Agency responds to the European Ombudsman?s letter regarding redacted documents.

Essentra has signed an agreement to acquire Clondalkin's Specialist Packaging Division for a cash consideration of approximately $455 million.

Consort announced that it has completed the acquisition of Aesica.

Facility will provide manufacturing services for inhalation, liquids, topicals and oral solids dosage forms

Catalent Pharma Solutions announces additional packaging and storage space for highly potent and cytotocix drugs at Kansas City facility.

Capsugel gives lead users access to intrinsically enteric capsule technology and support services.

SGS Life Science Services has been awarded cGMP accreditation from AIFA for its analytical laboratory in Livorno, Italy.

Roche announced it will spend 450 million Swiss Francs on a new manufacturing facility in Suzhou, China.

FDA releases guidance specifying its preferred unique facility identifier system.

FDA gives orphan drug designation to Merrimack Pharmaceuticals MM-141 for the treatment of pancreatic cancer.

Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark.